K Number
K211188
Manufacturer
Date Cleared
2021-07-19

(90 days)

Product Code
Regulation Number
882.4560
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The xvision Spine System, with xvision System Software, is intended as an aid for precisely locating anatomical structures in either open or percutaneous spine procedures. Their use is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the spine or pelvis, can be identified relative to CT imagery of the anatomy. This can include the spinal implant procedures, such as Posterior Pedicle Screw Placement in the thoracic and sacro-lumbar region.

The Headset of the xvision Spine System displays 2D stereotaxic screens and a virtual anatomy screen. The stereotaxic screen is indicated for correlating the tracked instrument location to the registered patient imagery. The virtual screen is indicated for displaying the virtual instrument location to the virtual anatomy to assist in percutaneous visualization and traiectory planning.

The virtual display should not be relied upon solely for absolute positional information and should always be used in conjunction with the displayed stereotaxic information

Device Description

The xvision Spine (XVS) system is an image-guided navigation system that is designed to assist surgeons in placing pedicle screws accurately, during open or percutaneous computer-assisted spinal surgery. The system consists of a dedicated software, Headset, single use passive reflective markers and reusable components. It uses wireless optical tracking technology and displays to the surgeon the location of the tracked surgical instruments relative to the acquired intraoperative patient's scan, onto the surgical field. The 2D scanned data and 3D reconstructed model, along with tracking information, are projected to the surgeons' retina using a transparent near-eye-display Headset, allowing the surgeon to both look at the patient and the navigation data at the same time.

AI/ML Overview

Here's an analysis of the acceptance criteria and the study proving the device meets them, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance:

Acceptance Criteria (Stated)Reported Device Performance
System Level Accuracy with a mean 3D positional error of 2.0mm and mean trajectory error of Phantom and Cadaver Studies: - Mean positional error: 2.32mm (99% UBL= 2.58mm) - Mean angular error: 1.66° (99% UBL=1.93°) Statistically significantly lower than 3mm positional and 3 degrees angular error.
Clinical accuracy for pedicle screw placement in sacral/lumbar vertebrae (Gertzbein score)A total accuracy of 97.7% demonstrated. Very similar to the literature control rate of 95%.
Electrical safetyTested in accordance with ANSI AAMI ES60601-1:2005/(R)2012 and A1:2012,C1:2009/(R)2012 and A2:2010/(R)2012. Successfully completed.
Electromagnetic Compatibility (EMC)Tested in accordance with IEC 60601-1-2:2014. Successfully completed.
Sterilization validation for single-use componentsConducted in accordance with ANSI AAMI ISO 11137-1:2006/(R)2015. Shelf life and packaging testing performed. All tests successfully completed.
Cleaning and steam sterilization validation for reusable componentsCleaning: AAMI TIR30:2011. Steam sterilization: ANSI/AAMI/ISO 17665-1:2006/(R)2013 and ANSI/AAMI/ISO 14937:2009/(R)2013. Successfully completed.
Biocompatibility of patient contact materialsVerified according to ISO 10993-1:2018 and FDA guidance on the use of ISO 10993-1, June 16, 2016. All tests successfully completed.
Software verification and validationConducted as required by IEC 62304 and FDA guidance on general principles of software validation, January 11, 2002.

Note: While the reported positional error (2.32mm) is higher than the stated acceptance criteria (2.0mm), the text explicitly states it's "statistically significantly lower than 3mm," which implies it met a broader acceptable threshold or was deemed clinically acceptable despite exceeding the initial numerical target slightly.

2. Sample size used for the test set and the data provenance:

  • Cadaver Study (Accuracy): The sample size for the cadaver study is not explicitly stated as a number of cadavers or individual pedicle screws. It generically mentions "pedicle screws were positioned percutaneously in thoracic and sacro-lumbar vertebrae."
    • Provenance: This was an ex-vivo study (cadaver study), implying it likely occurred in a controlled lab environment. No specific country of origin is mentioned, but the submitter is based in Israel.
  • Clinical Study (Clinical Accuracy):
    • Sample Size: Seventeen (17) subjects.
    • Provenance: Prospective, single-arm, multicenter study. No specific country of origin for the clinical sites is provided.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

  • Cadaver Study: The text does not explicitly state the number of experts or their qualifications for establishing ground truth (e.g., measuring actual screw tip positions from post-op scans). This aspect is implicit in the "calculated as the difference between the actual screw tip position... and its virtual tip" description.
  • Clinical Study: The ground truth for clinical accuracy was established using the Gertzbein score by "viewing the post-op scans." The number and qualifications of experts (e.g., experienced radiologists, spine surgeons) assessing the Gertzbein score are not specified in the provided text.

4. Adjudication method for the test set:

  • The text does not explicitly describe an adjudication method (like 2+1, 3+1) for either the cadaver or the clinical study. It mentions the Gertzbein score being assessed by "viewing the post-op scans," but not how discrepancies among multiple reviewers, if any were used, would be resolved.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, and if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

  • No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The studies described focus on the standalone performance of the xvision Spine system, not on its impact on human reader performance or a comparison of human readers with and without AI assistance. The device is an image-guided navigation system for surgical procedures, assisting the surgeon directly during the procedure rather than improving pre-operative image interpretation by radiologists.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

  • Yes, standalone performance was evaluated. The "System Level Accuracy" criteria and the results from both the bench testing (phantoms) and the cadaver study directly assess the accuracy of the device itself (positional and angular errors) without human in-the-loop influence on the measurement of accuracy. The clinical study also measures the system's accuracy in a real-world setting using post-operative scans.

7. The type of ground truth used:

  • Bench Testing (Phantoms): The ground truth was established by the known mechanical properties and precise measurements within the phantom setup, as well as presumably known parameters for partial detectability scenarios.
  • Cadaver Study: Ground truth was established by comparing the device's recorded "virtual tip" and "virtual trajectory" to the "actual screw tip position" and "screw orientation" derived from post-operative imaging scans.
  • Clinical Study: Ground truth for clinical accuracy was based on the Gertzbein score obtained from viewing post-operative imaging scans. The Gertzbein score implicitly provides a categorization of screw placement accuracy (e.g., ideal, acceptable, minor breach, major breach).

8. The sample size for the training set:

  • The text does not provide any information about the sample size used for the training set of the xvision Spine system's algorithms. It focuses entirely on verification and validation testing.

9. How the ground truth for the training set was established:

  • Since no information about a training set is provided, there is no information on how its ground truth was established.

{0}------------------------------------------------

July 19, 2021

Image /page/0/Picture/1 description: The image contains the logos of the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA). The HHS logo is on the left and features a stylized human figure. The FDA logo is on the right and includes the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

Augmedics Ltd % Janice Hogan Regulatory Counsel Hogan Lovells US LLP 1735 Market Street. Floor 23 Philadelphia, Pennsylvania 19103

Re: K211188

Trade/Device Name: xvision Spine (XVS) Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: April 20, 2021 Received: April 20, 2021

Dear Janice Hogan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

For: Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair, and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use

510(k) Number (if known)

K211188

Device Name

xvision Spine (XVS)

Indications for Use (Describe)

The xvision Spine System, with xvision System Software, is intended as an aid for precisely locating anatomical structures in either open or percutaneous spine procedures. Their use is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the spine or pelvis, can be identified relative to CT imagery of the anatomy. This can include the spinal implant procedures, such as Posterior Pedicle Screw Placement in the thoracic and sacro-lumbar region.

The Headset of the xvision Spine System displays 2D stereotaxic screens and a virtual anatomy screen. The stereotaxic screen is indicated for correlating the tracked instrument location to the registered patient imagery. The virtual screen is indicated for displaying the virtual instrument location to the virtual anatomy to assist in percutaneous visualization and traiectory planning.

The virtual display should not be relied upon solely for absolute positional information and should always be used in conjunction with the displayed stereotaxic information

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

K211188

510(k) SUMMARY

Augmedics' xvision Spine system

Submitter

Augmedics Ltd. 1 Ha-Tsmikha St. Yokneam Illit, 2069205 Israel

Phone: +972-4-3730111 Facsimile: +972-4-3730850

Contact Person: Tami Harel Date Prepared: April 20, 2021

Name of Device: xvision Spine

Common or Usual Name: XVS

Classification Name: Orthopedic Stereotaxic Instrument (21 CFR 882.4560)

Regulatory Class: Class II

Product Code: OLO

Predicate Devices: xvision Spine, manufactured by Augmedics Ltd. Israel (K190929)

Reference Device: VV FLUORO 3D, manufactured by Brainlab AG, Germany (K070106)

Intended Use / Indications for Use

The xvision Spine System, with xvision Spine System Software, is intended as an aid for precisely locating anatomical structures in either open or percutaneous spine procedures. Their use is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as the spine or pelvis, can be identified relative to CT imagery of the anatomy. This can include the spinal implant procedures, such as Posterior Pedicle Screw Placement in the thoracic and sacro-lumbar region.

The Headset of the xvision Spine System displays 2D stereotaxic screens and a virtual anatomy screen. The stereotaxic screen is indicated for correlating the tracked instrument location to the registered patient imagery. The virtual screen is indicated for displaying the virtual instrument location in relation to the virtual anatomy to assist in percutaneous visualization and trajectory planning.

The virtual display should not be relied upon solely for absolute positional information and should always be used in conjunction with the displayed stereotaxic information.

Device Description

The xvision Spine (XVS) system is an image-guided navigation system that is designed to assist surgeons in placing pedicle screws accurately, during open or percutaneous computer-assisted

{4}------------------------------------------------

spinal surgery. The system consists of a dedicated software, Headset, single use passive reflective markers and reusable components. It uses wireless optical tracking technology and displays to the surgeon the location of the tracked surgical instruments relative to the acquired intraoperative patient's scan, onto the surgical field. The 2D scanned data and 3D reconstructed model, along with tracking information, are projected to the surgeons' retina using a transparent near-eye-display Headset, allowing the surgeon to both look at the patient and the navigation data at the same time.

The principal technological differences between the XVS and its predicate include the addition of another registration method (X-link) compared to the single registration method for the predicate (Zlink); an additional option of a rigid reference point on the pelvis, in addition to the rigid reference point on the spine included in the predicate device; and improvements to the registration and tracking algorithms enabling successful registration and continuous tracking even when not all radiopaque beads and reflective points are detected.

Summary of Technological Characteristics

The modified xvision Spine System is similar in its technological features to its predicate device, the cleared xvision Spine systems include very similar hardware and software components, with the following basic components: software, Headset with optical tracking camera, single use passive reflective markers, rigid reference point, and reusable tool adaptors. The Headset in both systems is positioned on the surgeon's head and is designed to provide 2D and stereoscopic 3D augmented reality (AR) display with overlaid navigation information, onto patient's anatomy. The software in both systems is designed for real time calculation and display of the spatial position of the tip of the surgical instruments relative to patient's anatomy. Both systems share the same safety features and are compatible with the same intraoperative scanners. Both systems follow similar fundamental principles of operation.

xvision Spinexvision Spine (K190929)Conclusion
(subject device)(predicate device)
Intended Use /Indication forUseThe xvision Spine System, withxvision Spine System Software,is intended as an aid forprecisely locating anatomicalstructures in either open orpercutaneous spine procedures.Their use is indicated for anymedical condition in which theuse of stereotactic surgery maybe appropriate, and wherereference to a rigid anatomicalstructure, such as the spine orpelvis, can be identified relativeto CT imagery of the anatomy.This can include the spinalThe xvision Spine System, withxvision Spine System Software, isintended as an aid for preciselylocating anatomical structures ineither open or percutaneousspine procedures. Their use isindicated for any medicalcondition in which the use ofstereotactic surgery may beappropriate, and where referenceto a rigid anatomical structure,such as the spine, can beidentified relative to CT imageryof the anatomy. This can includethe spinal implant procedures,Similar.The pelvis wasadded as anadditional rigidanatomicalstructure tosupport theaddition of theXVS Perc Pin.This changedoes not alter theintended use ofthe device anddoes not change
implant procedures, such asPosterior Pedicle Screwsuch as Posterior Pedicle ScrewPlacement in the thoracic andits fundamentaltechnology or
xvision Spine(subject device)xvision Spine (K190929)(predicate device)Conclusion
Placement in the thoracic andsacro-lumbar region.The Headset of the xvisionSpine System displays 2Dstereotaxic screens and a virtualanatomy screen. Thestereotaxic screen is indicatedfor correlating the trackedinstrument location to theregistered patient imagery. Thevirtual screen is indicated fordisplaying the virtual instrumentlocation in relation to the virtualanatomy to assist inpercutaneous visualization andtrajectory planning.The virtual display should not berelied upon solely for absolutepositional information andshould always be used inconjunction with the displayedstereotaxic informationsacro-lumbar region.The Headset of the xvision SpineSystem displays 2D stereotaxicscreens and a virtual anatomyscreen. The stereotaxic screen isindicated for correlating thetracked instrument location to theregistered patient imagery. Thevirtual screen is indicated fordisplaying the virtual instrumentlocation in relation to the virtualanatomy to assist inpercutaneous visualization andtrajectory planning.The virtual display should not berelied upon solely for absolutepositional information and shouldalways be used in conjunctionwith the displayed stereotaxicinformationprinciples ofoperation.
User PopulationOrthopedic surgeons orneurosurgeonsOrthopedic surgeons orneurosurgeonsIdentical
Intended UseEnvironmentOperating RoomOperating RoomIdentical
Main systemcomponents• Headset with near eye see-through display and trackingcamera• Software application• Flat reflective markers• Tool adaptors• Reference point• Accessories: Panel PC, RollStand, 8" Tablet (Remote UI),VESA docking station for 8"Tablet• Headset with near eye see-through display and trackingcamera• Software application• Flat reflective markers• Tool adaptors• Reference pointSimilar.Providingaccessories asopposed torequiring theuser to purchasethem separatelydoes not raiseany newquestions ofsafety andeffectiveness.
Modes ofOperation• Patient Preparation• System Set-up• Intraoperative scan• Scan Import• Patient Registration• Navigation• Patient Preparation• System Set-up• Intraoperative scan• Scan Import• Patient Registration• NavigationIdentical
RegistrationMethods• Z link - registrationtransformation matrix iscalculated based on theknown mechanical position ofZ link - registration transformationmatrix is calculated based on theknown mechanical position of theregistration marker from theSimilar.Both registrationmethods are
xvision Spine(subject device)xvision Spine (K190929)(predicate device)Conclusion
the registration marker from the reference frame• X link – registration transformation matrix is calculated based on the calculated relative position of an optical registration marker positioned near the reference framereference framebased on the same fundamental technology and principles of operation. No new questions of safety or effectiveness are raised based on the difference between the Z-link and X-link methods, and the use of the Automatic Registration of the reference device further supports the substantial equivalence of this additional feature
Rigid referencepoint• Patient Clamp attached to the spinous process• Perc Pin inserted into the PSIS• Off-the-shelf Schantz screws• Patient Clamp attached to the spinous processSimilar. Additional options for a rigid reference point do not alter the intended use of the device or raise new safety or performance questions. The questions of stability, biocompatibility and sterility are common to all configurations of a rigid reference point.
Instrument(Tool) Adaptors• Reusable• universal (connects to various tools, not system-specific)• VP & Ergonomic (system specific adaptors)• Reusable• universal (connects to various tools, not system-specific)Similar. All configurations of Tool Adaptors share the same risk of improper fixation of the reflective marker to the surgical
xvision Spine(subject device)xvision Spine (K190929)(predicate device)Conclusion
LocalizationTechnologyOpticalOpticalsystem. Thedesign mitigationfor this risk isidentical for allconfigurations.Thus, no newquestions ofsafety andperformance areraisedIdentical
ReflectiveMarkers• Flat• Single use, provided sterile• Sterilized by GammaRadiation• Flat• Single use, provided sterile• Sterilized by Gamma RadiationIdentical
Optical TrackerSingle infrared camera,positioned 0.5m above trackedobjectsSingle infrared camera,positioned 0.5m above trackedobjectsIdentical
Tracking6 DOF6 DOFIdentical
SystemAccuracyRequirementSystem Level Accuracy with amean 3D positional error of2.0mm and mean trajectoryerror of 2°System Level Accuracy with amean 3D positional error of2.0mm and mean trajectory errorof 2°Identical
ImagingModalityX-Ray Based ImagingX-Ray Based ImagingIdentical
Medical DeviceInterfacesO-arm Imaging SystemZiehm Vision FD Vario 3D C-Arm and RFD 3DSiemens CIOS SPinAiro system by BrainlabO-arm Imaging SystemZiehm Vision FD Vario 3D C-Armand RFD 3DSiemens CIOS SPinAiro system by BrainlabIdentical
CommunicationbetweenScanner andplatform/computerUSB & LAN connectivity usingDICOMUSB & LAN connectivity usingDICOMIdentical
Display andOpticsTechnologyAugmented Reality using neareye see-through display; datadisplayed on patient's anatomyAugmented Reality using neareye see-through display; datadisplayed on patient's anatomyIdentical
CommunicationbetweenHeadset andcomputerWireless, encryptedWireless, encryptedIdentical
Supported2.4GHZ & 5 GHz:2.4GHz:Similar.
xvision Spine(subject device)xvision Spine (K190929)(predicate device)Conclusion
Frequencies &Transmissionprotocols802.11g/n/ac802.11gSupportadditionaltransmissionfrequency andprotocolincreasescommunicationrate. No newsafety or efficacyquestions areraised due to thismodification
Frame rate ofdisplayedimages60 fps60 fpsIdentical
Pixel resolution1280x720 per eye1280x720 per eyeIdentical
Headset powersourceLi-ion rechargeable batteryLi-ion rechargeable batteryIdentical
Number ofsupportedHeadsetsTwoTwoIdentical

A table comparing the key features of the subject and the predicate devices is provided below:

{5}------------------------------------------------

{6}------------------------------------------------

{7}------------------------------------------------

{8}------------------------------------------------

Performance Data:

The following testing was conducted to evaluate the device:

  • . Bench testing was conducted in order to demonstrate that the xvision-Spine system performs according to its requirements and specifications. In particular, overall system accuracy, image registration accuracy and tracking accuracy were tested using phantoms, under different conditions simulating clinical conditions such as: Headset mounted statically and Headset moving above the markers, different distances between the Headset and the markers, different angles, partial detectability of the radiopaque beads and reflective points in the scan and IR image, and different registration methods (Z-link and X-link). The Z-link method uses a known mechanical position between the registration marker and the rigid reference marker, and the X-link method, calculates this position using the optical tracker. Under all test conditions, the average and standard deviation of the system's positional and angular errors were substantially equivalent to the predicate and met acceptance criteria.
    Additionally, tracking accuracy was verified per ASTM F2554-18.

  • . The System's accuracy was also validated in a cadaver study, in which pedicle screws were positioned percutaneously in thoracic and sacro-lumbar vertebrae, using the Perc Pin as the rigid reference point. Both Z-link and X-link registration methods were used. The positional

{9}------------------------------------------------

error was calculated as the difference between the actual screw tip position, derived from the post-op scan, and its virtual tip, as recorded by the xvision-Spine system. The trajectory error was calculated as the difference between the screw orientation and its recorded virtual trajectory. An overall mean positional error of 2.32mm (99% UBL*= 2.58mm) and angular error of 1.66º (99% UBL*=1.93º) was measured. Thus, the system has demonstrated performance in 3D positional accuracy with a mean error statistically significantly lower than 3mm and in trajectory angle accuracy with a mean error statistically significantly lower than 3 degrees, both in phantom and cadaver studies.

  • . The System's clinical accuracy, using the X-link registration method was validated in a prospective, single arm multicenter study. System's accuracy was evaluated using the Gertzbein score by viewing the post-op scans. A total accuracy of 97.7% was demonstrated for seventeen (17) subjects who were scheduled for elective open spinal surgery that required posterior pedicle screw placement in the sacral/lumbar vertebrae. The accuracy of the XVS system was found to be very similar to the literature control rate of 95%.
  • . Electrical safety was tested in accordance with ANSI AAMI ES60601-1:2005/(R)2012 and A1:2012,C1:2009/(R)2012 and A2:2010/(R)2012 - Medical electrical equipment - Part 1: General requirements for basic safety and essential performance.
  • . Electromagnetic Compatibility (EMC) was tested in accordance with IEC 60601-1-2:2014 -Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests.
  • . Sterilization validation for the single use components was conducted in accordance with the ANSI AAMI ISO 11137-1:2006/(R)2015. Additionally, shelf life and packaging testing were performed to support the labeled shelf life. All tests were successfully completed.
  • . Reusable components were validated for cleaning, in accordance with the AAMI TIR30:2011 guidance, and for steam sterilization, in compliance with the partial cycle validation approach outlined in ANSI/AAMI/ISO 17665-1:2006/(R)2013 and the validation approach outlined in ANSI/AAMI/ISO 14937:2009/(R)2013
  • . The biocompatibility of all patient contact materials was verified according to ISO 10993-1:2018 and FDA guidance on the use of ISO 10993-1, June 16, 2016. All tests were successfully completed.
  • Software verification and validation testing was conducted as required by IEC 62304 and . FDA guidance on general principles of software validation, January 11, 2002.

All performance testing demonstrates that the xvision System performs according to specifications and functions as intended.

{10}------------------------------------------------

Conclusions

The xvision Spine System is substantially equivalent to its predicate, the cleared xvision Spine System. Both systems have the same intended use and similar indications, technological characteristics, and principles of operation. The minor differences in indications do not alter the intended surgical use of the device and do not affect its safety and effectiveness when used as labeled. None of the minor differences raise new types of safety or effectiveness questions. Performance data demonstrated that the xvision Spine system functions as intended.

§ 882.4560 Stereotaxic instrument.

(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).